Revisiting Enzyme Replacement Therapy for Aspartylglucosaminuria: Truncated Phosphotransferase Enhances Mannose‐6‐Phosphorylation and Cellular Uptake of Aspartylglucosaminidase

Antje Banning, Lidia Reznikova, Adla Murad, Ritva Tikkanen

Open source

DOI
10.1002/jimd.70248
Published
2026-09
Container
Journal of Inherited Metabolic Disease
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/jimd.70248,
  title = {Revisiting Enzyme Replacement Therapy for Aspartylglucosaminuria: Truncated Phosphotransferase Enhances Mannose‐6‐Phosphorylation and Cellular Uptake of Aspartylglucosaminidase},
  author = {Antje Banning and Lidia Reznikova and Adla Murad and Ritva Tikkanen},
  year = {2026},
  journal = {Journal of Inherited Metabolic Disease},
  doi = {10.1002/jimd.70248},
  url = {https://doi.org/10.1002/jimd.70248}
}

RIS

TY  - JOUR
TI  - Revisiting Enzyme Replacement Therapy for Aspartylglucosaminuria: Truncated Phosphotransferase Enhances Mannose‐6‐Phosphorylation and Cellular Uptake of Aspartylglucosaminidase
AU  - Antje Banning
AU  - Lidia Reznikova
AU  - Adla Murad
AU  - Ritva Tikkanen
PY  - 2026
JO  - Journal of Inherited Metabolic Disease
DO  - 10.1002/jimd.70248
UR  - https://doi.org/10.1002/jimd.70248
ER  - 

APA

Banning, A., Reznikova, L., Murad, A., & Tikkanen, R. (2026). Revisiting Enzyme Replacement Therapy for Aspartylglucosaminuria: Truncated Phosphotransferase Enhances Mannose‐6‐Phosphorylation and Cellular Uptake of Aspartylglucosaminidase. Journal of Inherited Metabolic Disease. https://doi.org/10.1002/jimd.70248

Source records